EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

In The News

India Pharma Exports Hit $8.1B in Q1 FY27, Vaccines Surge 36% - India’s pharmaceutical exports rose 6.8% year-on-year to reach US$ 8.1 billion in the first quarter of FY27 (April–June 2026), according to industry data reported by Indian Pharma Post and ANI News. The growth comes despite ongoing tariff uncertainties and global shipping disruptions that have pressured the sector throughout 2026. 📊 Export Growth: The Numbers The […]
India Pharma 2030 Export Target Cut to $90 Billion Amid Tariff and Shipping Crisis - India’s pharmaceutical industry is on track to miss its ambitious 2030 export target of $130 billion, with sector leaders now projecting a revised figure of approximately $90 billion — a shortfall driven by a combination of US tariff pressures, Red Sea shipping disruptions, and a dearth of new drug approvals, according to industry trade body […]
CDSCO Digital Drug Platform: End-to-End Regulatory System in 18 Months - India’s drug regulator is building a fully digital, end-to-end regulatory platform — and the first phase is expected to go live within 18 months. The announcement, made by Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi, marks the most significant overhaul of India’s drug approval infrastructure in decades. 📦 What Is the Digital Drug […]
India’s CDSCO Digital Drug Platform to Fast-Track Approvals - India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is pushing forward with the most significant digital overhaul of its drug approval system in years. The Central Drugs Laboratory (CDL) and CDSCO headquarters have confirmed plans to launch the first phase of an end-to-end digital drug regulatory platform within the next 18 months, alongside […]

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Stay Connected

If you have any question,please connect us.

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities